Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with Bipolarity: searching for the antidepressant and mood stabilising neurophysiology
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with bipolarity. Other eligibility criteria apply.
- Listed locations
- Germany
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Recruitment unclear
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Department of Psychiatry, RWTH Aachen
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2007-000479-40
- Official title
Show the full official title
Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology
Recruitment & locations
Germany
Registry details
- Germany — Ongoing
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Department of Psychiatry, RWTH Aachen.
Who can participate?
This study is for people with bipolarity. Other eligibility criteria apply.
